Induction of apoptosis in B lymphoma cells by activation with CD40L

被引：2
|
作者：
Lefterova, P
Märten, A
Buttgereit, P
Schakowski, F
Micka, B
Scheffold, C
Schmidt-Wolf, IGH
机构：
[1] Univ Bonn, Med Klin & Poliklin 1, D-53105 Bonn, Germany
[2] Stanford Univ, Bone Marrow Transplant Program, Stanford, CA 94305 USA
来源：
ACTA HAEMATOLOGICA | 2000年 / 103卷 / 03期
关键词：
D O I：
10.1159/000041042
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：168 / 171
页数：4
相关论文
共 50 条
  • [11] CD40L induces multidrug resistance to apoptosis in breast carcinoma and lymphoma cells through caspase independent and dependent pathways
    Nathalie Voorzanger-Rousselot
    Laurent Alberti
    Jean-Yves Blay
    BMC Cancer, 6
  • [12] CD40L induces multidrug resistance to apoptosis in breast carcinoma and lymphoma cells through caspase independent and dependent pathways
    Voorzanger-Rousselot, N
    Alberti, L
    Blay, JY
    BMC CANCER, 2006, 6 (1)
  • [13] Large B cell lymphoma cells utilize a CD40/CD40L/NK-κB signalosome for mediating dysregulated cell proliferation.
    Ford, RJ
    Tamayo, A
    Terry, NH
    Pham, L
    BLOOD, 2000, 96 (11) : 335A - 335A
  • [14] CD40/CD40L interactions and cytokines regulate HIV replication in B cells in vitro
    Gras, G
    Legendre, C
    Krzysiek, R
    Dormont, D
    Galanaud, P
    Richard, Y
    VIROLOGY, 1996, 220 (02) : 309 - 319
  • [15] CD28/CTLA-4/B7 and CD40/CD40L costimulation and activation of regulatory T cells
    Isabel T Vogel
    Stefaan W Van Gool
    Jan L Ceuppens
    World Journal of Immunology, 2014, 4 (02) : 63 - 77
  • [16] CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells
    Naito, Masayasu
    Hainz, Ursula
    Burkhardt, Ute E.
    Fu, Buyin
    Ahove, Deborah
    Stevenson, Kristen E.
    Rajasagi, Mohini
    Zhu, Baogong
    Alonso, Anselmo
    Witten, Elizabeth
    Matsuoka, Ken-ichi
    Neuberg, Donna
    Duke-Cohan, Jonathan S.
    Wu, Catherine J.
    Freeman, Gordon J.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2013, 62 (02) : 347 - 357
  • [17] CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells
    Masayasu Naito
    Ursula Hainz
    Ute E. Burkhardt
    Buyin Fu
    Deborah Ahove
    Kristen E. Stevenson
    Mohini Rajasagi
    Baogong Zhu
    Anselmo Alonso
    Elizabeth Witten
    Ken-ichi Matsuoka
    Donna Neuberg
    Jonathan S. Duke-Cohan
    Catherine J. Wu
    Gordon J. Freeman
    Cancer Immunology, Immunotherapy, 2013, 62 : 347 - 357
  • [18] Targeted delivery of CD40L promotes restricted activation of antigen-presenting cells and induction of cancer cell death
    Kim L Brunekreeft
    Corinna Strohm
    Marloes J Gooden
    Anna A Rybczynska
    Hans W Nijman
    Götz U Grigoleit
    Wijnand Helfrich
    Edwin Bremer
    Daniela Siegmund
    Harald Wajant
    Marco de Bruyn
    Molecular Cancer, 13
  • [19] Targeted delivery of CD40L promotes restricted activation of antigen-presenting cells and induction of cancer cell death
    Brunekreeft, Kim L.
    Strohm, Corinna
    Gooden, Marloes J.
    Rybczynska, Anna A.
    Nijman, Hans W.
    Grigoleit, Goetz U.
    Helfrich, Wijnand
    Bremer, Edwin
    Siegmund, Daniela
    Wajant, Harald
    de Bruyn, Marco
    MOLECULAR CANCER, 2014, 13
  • [20] The role of CD40 and CD154/CD40L in dendritic cells
    Ma, Daphne Y.
    Clark, Edward A.
    SEMINARS IN IMMUNOLOGY, 2009, 21 (05) : 265 - 272
12345